Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
6.88
-0.07 (-1.01%)
Apr 30, 2025, 3:04 PM CST
SHE:002198 Revenue
Guangdong Jiaying Pharmaceutical had revenue of 121.63M CNY in the quarter ending March 31, 2025, with 28.83% growth. This brings the company's revenue in the last twelve months to 403.38M, down -19.19% year-over-year. In the year 2024, Guangdong Jiaying Pharmaceutical had annual revenue of 376.17M, down -29.46%.
Revenue (ttm)
403.38M
Revenue Growth
-19.19%
P/S Ratio
8.66
Revenue / Employee
576.26K
Employees
700
Market Cap
3.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 376.17M | -157.07M | -29.46% |
Dec 31, 2023 | 533.23M | -125.96M | -19.11% |
Jan 1, 2023 | 659.20M | 84.48M | 14.70% |
Jan 1, 2022 | 574.71M | 29.98M | 5.50% |
Dec 31, 2020 | 544.73M | 44.22M | 8.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |